Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Norfolk Southern
NSC
|
$976M |
| 2 |
Baker Hughes
BKR
|
$310M |
| 3 |
Truist Financial
TFC
|
$303M |
| 4 |
CVS Health
CVS
|
$236M |
| 5 |
Alibaba
BABA
|
$164M |
Top Sells
| 1 |
GE Aerospace
GE
|
$1.12B |
| 2 |
Meta Platforms (Facebook)
META
|
$766M |
| 3 |
Molson Coors Class B
TAP
|
$656M |
| 4 |
FedEx
FDX
|
$504M |
| 5 |
Novartis
NVS
|
$394M |
Sector Composition
| 1 | Financials | 20.67% |
| 2 | Healthcare | 18.6% |
| 3 | Technology | 17.71% |
| 4 | Communication Services | 12.88% |
| 5 | Industrials | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Molson Coors Class B
TAP
$9.98B
| $1.2B | 0.8% | 18,153,474 -9,966,580 | -35% | -$656M |
|
52
Ovintiv
OVV
$10.8B
| $1.12B | 0.75% | 29,360,276 +2,344,256 | +9% | +$89.2M |
|
|
53
CVS Health
CVS
$92.8B
| $1.11B | 0.74% | 16,024,422 +3,417,573 | +27% | +$236M |
|
|
JNPR
54
DELISTED
Juniper Networks
JNPR
| $1.1B | 0.73% | 34,983,530 -150,722 | -0.4% | -$4.72M |
|
55
Bristol-Myers Squibb
BMY
$96B
| $1.05B | 0.7% | 16,404,346 -64,836 | -0.4% | -$4.15M |
|
56
Coherent
COHR
$14.1B
| $1.02B | 0.68% | 19,921,620 +578,925 | +3% | +$29.5M |
|
|
57
Norfolk Southern
NSC
$62.8B
| $976M | 0.65% | 4,306,139 +4,302,589 | +121,200% | +$976M |
|
58
Hewlett Packard
HPE
$29.6B
| $929M | 0.62% | 55,283,423 -2,193,852 | -4% | -$36.9M |
|
59
Haleon
HLN
$43.9B
| $927M | 0.62% | 110,626,894 -1,428,711 | -1% | -$12M |
|
|
60
Truist Financial
TFC
$60.4B
| $922M | 0.62% | 30,391,734 +9,980,937 | +49% | +$303M |
|
61
Dell
DELL
$82.6B
| $896M | 0.6% | 16,563,958 -1,908,993 | -10% | -$103M |
|
62
Elanco Animal Health
ELAN
$9.12B
| $851M | 0.57% | 84,621,350 -152,725 | -0.2% | -$1.54M |
|
63
Teck Resources
TECK
$16.7B
| $832M | 0.56% | 19,765,040 -7,926,000 | -29% | -$334M |
|
64
Celanese
CE
$5.22B
| $813M | 0.54% | 7,017,687 -60,165 | -0.9% | -$6.97M |
|
65
XP
XP
$9.56B
| $807M | 0.54% | 34,406,121 -1,393,604 | -4% | -$32.7M |
|
66
Dominion Energy
D
$51.1B
| $799M | 0.53% | 15,429,108 +603,475 | +4% | +$31.3M |
|
67
Credicorp
BAP
$20.4B
| $797M | 0.53% | 5,400,431 -140,131 | -3% | -$20.7M |
|
68
Carrier Global
CARR
$55.5B
| $729M | 0.49% | 14,663,181 -230,000 | -2% | -$11.4M |
|
69
Alnylam Pharmaceuticals
ALNY
$58.5B
| $720M | 0.48% | 3,789,525 -105,010 | -3% | -$19.9M |
|
70
Zimmer Biomet
ZBH
$21B
| $708M | 0.47% | 4,864,500 -57,250 | -1% | -$8.34M |
|
71
Nutrien
NTR
$28B
| $683M | 0.46% | 11,572,059 +38,700 | +0.3% | +$2.29M |
|
72
Aegon
AEG
$12.3B
| $639M | 0.43% | 126,016,146 +207,351 | +0.2% | +$1.05M |
|
73
Medtronic
MDT
$119B
| $619M | 0.41% | 7,031,090 -152,800 | -2% | -$13.5M |
|
74
JD.com
JD
$44.1B
| $554M | 0.37% | 16,237,049 +2,015,100 | +14% | +$68.8M |
|
75
Occidental Petroleum Corporation Warrants to Purchase Common Stock
OXY.WS
$24B
| $534M | 0.36% | 14,298,818 -20,561 | -0.1% | -$767K |
|